73 related articles for article (PubMed ID: 17568024)
1. Do cancer cells express functional erythropoietin receptors?
Longmore GD
N Engl J Med; 2007 Jun; 356(24):2447. PubMed ID: 17568024
[No Abstract] [Full Text] [Related]
2. Problems in identifying functional erythropoietin receptors in cancer tissue.
Jelkmann W; Laugsch M
J Clin Oncol; 2007 Apr; 25(12):1627-8; author reply 1628. PubMed ID: 17443006
[No Abstract] [Full Text] [Related]
3. Understanding the presence and function of erythropoietin receptors on cancer cells.
Lai SY; Grandis JR
J Clin Oncol; 2006 Oct; 24(29):4675-6. PubMed ID: 17028292
[No Abstract] [Full Text] [Related]
4. Erythropoietin receptors on cancer cells: a still open question.
Della Ragione F; Cucciolla V; Borriello A; Oliva A; Perrotta S
J Clin Oncol; 2007 May; 25(13):1812-3; author reply 1815. PubMed ID: 17470877
[No Abstract] [Full Text] [Related]
5. An erythropoietin autocrine/paracrine axis modulates the growth and survival of human prostate cancer cells.
Jeong JY; Hoxhaj G; Socha AL; Sytkowski AJ; Feldman L
Mol Cancer Res; 2009 Jul; 7(7):1150-7. PubMed ID: 19567780
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma multiforme cells: expression of erythropoietin receptor and response to erythropoietin.
Yin D; Kawabata H; Tcherniamtchouk O; Huynh T; Black KL; Koeffler HP
Int J Oncol; 2007 Nov; 31(5):1193-8. PubMed ID: 17912447
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin receptors on tumor cells: what do they mean?
Fandrey J
Oncologist; 2008; 13 Suppl 3():16-20. PubMed ID: 18458120
[TBL] [Abstract][Full Text] [Related]
8. Do erythropoietin receptors on cancer cells explain unexpected clinical findings?
Henke M; Mattern D; Pepe M; Bézay C; Weissenberger C; Werner M; Pajonk F
J Clin Oncol; 2006 Oct; 24(29):4708-13. PubMed ID: 17028293
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin: not just about erythropoiesis.
Ghezzi P; Bernaudin M; Bianchi R; Blomgren K; Brines M; Campana W; Cavaletti G; Cerami A; Chopp M; Coleman T; Digicaylioglu M; Ehrenreich H; Erbayraktar S; Erbayraktar Z; Gassmann M; Genc S; Gokmen N; Grasso G; Juul S; Lipton SA; Hand CC; Latini R; Lauria G; Leist M; Newton SS; Petit E; Probert L; Sfacteria A; Siren AL; Talan M; Thiemermann C; Westenbrink D; Yaqoob M; Zhu C
Lancet; 2010 Jun; 375(9732):2142. PubMed ID: 20609950
[No Abstract] [Full Text] [Related]
10. [Research advances in expression and functions of erythropoietin and erythropoietin receptor in cancers].
Li M; Lu Y; Chen XQ
Ai Zheng; 2008 Jun; 27(6):667-72. PubMed ID: 18570746
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin may impair, not improve, cancer survival.
Brower V
Nat Med; 2003 Dec; 9(12):1439. PubMed ID: 14647499
[No Abstract] [Full Text] [Related]
12. [Erythropoietin and radiotherapy].
Le Fur E; Albarghach MN; Pradier O
Cancer Radiother; 2010 Jan; 14(1):81-6. PubMed ID: 20018547
[TBL] [Abstract][Full Text] [Related]
13. Preclinical studies of erythropoietin receptor expression in tumour cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemia.
Osterborg A; Aapro M; Cornes P; Haselbeck A; Hayward CR; Jelkmann W
Eur J Cancer; 2007 Feb; 43(3):510-9. PubMed ID: 17150352
[TBL] [Abstract][Full Text] [Related]
14. Erythropoietin-dependent autocrine secretion of tumor necrosis factor-alpha in hematopoietic cells modulates proliferation via MAP kinase--ERK-1/2 and does not require tyrosine docking sites in the EPO receptor.
Chen J; Jacobs-Helber SM; Barber DL; Sawyer ST
Exp Cell Res; 2004 Aug; 298(1):155-66. PubMed ID: 15242770
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin biology in cancer.
Hardee ME; Arcasoy MO; Blackwell KL; Kirkpatrick JP; Dewhirst MW
Clin Cancer Res; 2006 Jan; 12(2):332-9. PubMed ID: 16428469
[TBL] [Abstract][Full Text] [Related]
16. Interrelation of directly measured oxygenation levels, erythropoietin and erythropoietin receptor expression in spontaneous canine tumours.
Rohrer Bley C; Wergin M; Roos M; Grenacher B; Kaser-Hotz B
Eur J Cancer; 2007 Mar; 43(5):963-7. PubMed ID: 17254768
[TBL] [Abstract][Full Text] [Related]
17. Hormone peptidomimetics: seeing double.
Braisted A
Nat Biotechnol; 1997 Nov; 15(12):1244-5. PubMed ID: 9359102
[No Abstract] [Full Text] [Related]
18. Erythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cells.
Feldman L; Wang Y; Rhim JS; Bhattacharya N; Loda M; Sytkowski AJ
Prostate; 2006 Feb; 66(2):135-45. PubMed ID: 16161153
[TBL] [Abstract][Full Text] [Related]
19. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
Um M; Gross AW; Lodish HF
Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
[TBL] [Abstract][Full Text] [Related]
20. No direct effects of erythropoietin beta on a head and neck squamous cell carcinoma cell line which is growth stimulated in vivo.
Sasaki Y; Kjellén E; Mineta H; Wennerberg J; Ekblad L
Acta Oncol; 2009; 48(7):1062-9. PubMed ID: 19412811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
